What Charles River Laboratories International, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 1 | 2 |
| Sells | 20 | 21 |
| Total trades | 37 | 119 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 108,833 | 470,574 |
| Disposed | 118,954 | 424,829 |
| Net activity | −10,121 | +45,745 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Foster James C | Director | Oct 22 | Disclosed 10b5-1 sale · S | −24,042 | $350.00 | −$8.41M | 31,596 |
| Foster James C | Director | Oct 22 | Exercise / conversion · M | +24,042 | $244.41 | +$5.88M | 55,638 |
| Parisotto Shannon M | CEVP, Disc & Safety Assessment | Oct 21 | Disclosed 10b5-1 sale · S | −2,156 | $344.41 | −$743K | 4,807 |
| Parisotto Shannon M | CEVP, Disc & Safety Assessment | Oct 21 | Exercise / conversion · M | +2,156 | $244.41 | +$527K | 6,963 |
| Parisotto Shannon M | CEVP, Disc & Safety Assessment | Oct 05 | Disclosed 10b5-1 sale · S | −981 | $308.44 | −$303K | 4,807 |
| Parisotto Shannon M | CEVP, Disc & Safety Assessment | Oct 05 | Exercise / conversion · M | +981 | $208.44 | +$204K | 5,788 |
| Coleman Glenn | EVP & Chief Financial Officer | Sep 30 | Open-market buy · P | +10 | $297.43 | +$2.97K | 27,762 |
| Foster James C | Director | Aug 25 | Disclosed 10b5-1 sale · S | −33,561 | $300.00 | −$10.1M | 31,596 |
| Foster James C | Director | Aug 25 | Exercise / conversion · M | +12,429 | $208.44 | +$2.59M | 65,157 |
| Foster James C | Director | Aug 25 | Exercise / conversion · M | +21,132 | $194.12 | +$4.1M | 52,728 |
| Girshick Birgit | Chief Executive Officer | Aug 19 | Gift · G | −528 | — | — | 35,485 |
| Parisotto Shannon M | CEVP, Disc & Safety Assessment | Aug 19 | Disclosed 10b5-1 sale · S | −2,039 | $294.12 | −$600K | 4,807 |
| Parisotto Shannon M | CEVP, Disc & Safety Assessment | Aug 19 | Exercise / conversion · M | +2,039 | $194.12 | +$396K | 6,846 |
| Andrews Nancy C | Director | Aug 18 | Open-market sale · S | −573 | $285.24 | −$163K | 1,438 |
| Andrews Nancy C | Director | Aug 18 | Exercise / conversion · M | +573 | $164.30 | +$94.1K | 2,011 |
| Parisotto Shannon M | CEVP, Disc & Safety Assessment | Aug 11 | Disclosed 10b5-1 sale · S | −3,714 | $279.66 | −$1.04M | 4,807 |
| Parisotto Shannon M | CEVP, Disc & Safety Assessment | Aug 11 | Exercise / conversion · M | +3,714 | $179.66 | +$667K | 8,521 |
| Girshick Birgit | Chief Executive Officer | Aug 11 | Disclosed 10b5-1 sale · S | −6,500 | $279.90 | −$1.82M | 36,013 |
| Girshick Birgit | Chief Executive Officer | Aug 11 | Exercise / conversion · M | +6,500 | $179.66 | +$1.17M | 42,513 |
| Foster James C | Director | Aug 10 | Disclosed 10b5-1 sale · S | −28,733 | $275.00 | −$7.9M | 31,596 |
Loading...